Skip to main content
峆一药业 logo

峆一药业 — Investor Relations & Filings

Ticker · 920478 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2024-07-18 Governance Information
Country CN China
Listing Beijing Stock Exchange 920478

About 峆一药业

http://www.heryipharma.com/

Anhui Heyi Pharmaceutical Co., Ltd. specializes in the research, development, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company focuses on providing high-quality chemical products for various therapeutic areas, including cardiovascular, central nervous system, and anti-infective treatments. With a strong emphasis on technological innovation and quality control, it operates advanced manufacturing facilities that adhere to international standards. Its product portfolio includes key intermediates for widely used medications, supporting both domestic and global pharmaceutical supply chains. The company leverages its expertise in complex chemical synthesis to offer customized solutions and reliable supply to its partners in the life sciences sector.

Recent filings

Filing Released Lang Actions
关于拟修订《公司章程》公告
Governance Information Classification · 95% confidence The document is an announcement regarding proposed amendments to the company's Articles of Association (公司章程). It details specific changes to registered capital and share capital following a completed equity distribution plan. The document states that these amendments will be submitted to the shareholders' meeting for approval. There is no financial report, audit, or detailed financial data included. The document is a formal announcement of governance-related changes, specifically to the company's internal rules and structure. Therefore, it fits best under Governance Information (CGR). The document length is short and it is not merely announcing the publication of a report, so it is not RPA or RNS.
2024-07-18 Chinese
关于召开 2024 年第一次临时股东大会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2024 first extraordinary general meeting of shareholders (临时股东大会) for Anhui Xuyi Pharmaceutical Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items such as nomination of a new director and proposed amendments to the company charter, registration procedures, and other logistical information. It does not contain any financial statements, audit information, or detailed financial results. It is not a report or transcript but a formal announcement of a shareholders meeting. Therefore, it fits the category of a shareholder meeting notice, which aligns with the category AGM Information (AGM-R). The document length is 2373 characters, which is relatively short and consistent with a meeting notice rather than a full report.
2024-07-18 Chinese
回购股份方案公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement regarding a share repurchase plan by 安徽峆一药业股份有限公司. It includes specifics about the type of shares to be repurchased, the purpose (employee stock ownership plan or equity incentives), the number of shares, price range, funding source, implementation period, and risk disclosures. It also contains board meeting resolutions approving the plan and authorizations for execution. The document is not a financial report, earnings release, or management discussion but a formal announcement of a share buyback program. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company announcements about share repurchases. The document length and detail confirm it is the announcement itself, not a brief notice or a report publication announcement.
2024-07-18 Chinese
关于取得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of an invention patent certificate issued by the National Intellectual Property Office. It includes details about the patent, its application and authorization dates, and the impact on the company. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no meeting materials, or voting results. The document is a regulatory announcement about intellectual property rights, which does not fit into financial report categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it is not about a report. It is best classified as a Regulatory Filing (RNS) as a general announcement that does not fit other categories.
2024-07-14 Chinese
关于使用募集资金向全资子公司提供借款以实施募投项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the use of funds raised from a public stock issuance to provide a loan to a wholly-owned subsidiary for project implementation. It includes details about the board and supervisory committee meetings approving the loan, references to regulatory approvals, and compliance with relevant securities exchange rules. The document does not contain financial statements or detailed financial performance data but rather focuses on the use of capital raised and internal approvals. The length is under 5,000 characters and it is an announcement of a financing-related decision rather than a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP).
2024-06-04 Chinese
第四届董事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 17th meeting of the 4th Board of Directors of Anhui Xuyi Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and compliance with company law and articles of association. The content focuses on board decisions, specifically regarding the use of raised funds for a subsidiary project. There is no financial report, audit, or earnings data presented. The document is not a report itself but an official announcement of board meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is short and it is a meeting resolution announcement, not a full report or presentation.
2024-06-04 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.